SM
ATRC icon

Sciencast Management’s AtriCure ATRC Stock Holding History

Sciencast Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,502
Closed -$242K – 542
2021
Q4 		$242K Buy
+3,502
New +$255K 0.04% 412
2021
Q1 		– Sell
-7,874
Closed -$445K – 487
2020
Q4 		$445K Buy
+7,874
New +$340K 0.09% 289

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sciencast Management's ATRC Position: Q1 2022 in Review

Sciencast Management sold out of AtriCure (ATRC) in Q1 2022, closing a stake of 3,502 shares — an estimated $242K sold.

Sciencast Management first reported a position in ATRC in Q4 2020 and held it in 2 quarters. The position peaked at $445K in Q4 2020. 217 funds tracked by Wall St. Rank hold ATRC as of Q1 2022.

  • Sciencast Management reported no remaining AtriCure position as of Q1 2022 after selling out during the quarter.
  • Sciencast Management sold 3,502 AtriCure shares in Q1 2022, an estimated $242K.
  • Sciencast Management first reported a position in AtriCure in Q4 2020 and held it in 2 quarters.
  • Sciencast Management's AtriCure position peaked at $445K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q1 2022.

Based on Sciencast Management's 13F filing for Q1 2022, filed 26 Apr 2022.